/15 Mar 2017/By Poonam Kaul, PhD Webinar Recap: Unlocking GPCR’s for Oncology Surprisingly few GPCR-targeted therapies have been developed for oncology, despite frequent disregulation of the receptors and their signaling mediators that control pro-survival... Read More